脓毒症患者生存的全基因组关联研究
本研究分两阶段进行:第一阶段对GEN-SEP网络中687例欧洲脓毒症患者使用750万个插补变异进行Cox回归分析,调整性别、年龄和遗传变异主要主成分;第二阶段在MESSI研究中针对优先变异对2063例ICU脓毒症患者(1362例欧洲裔美国人、701例非洲裔美国人)进行分析,并对两阶段结果进行荟萃分析,显著性阈值p<5.0×10^-8。研究发现三个独立低频变异与28天脓毒症生存率降低相关,包括SAMD9错义变异(HR 1.64 [95%CI 1.37-6.78],p=4.92×10^-8)。SAMD9编码组织损伤炎症反应的可能介质。作者认为需要更大样本研究验证这些遗传效应。
要点
- 在687例欧洲脓毒症患者和2063例ICU脓毒症患者中,SAMD9错义变异与28天生存率降低相关(HR 1.64,95%CI 1.37-6.78,p=4.92×10^-8)。
- 研究识别出三个独立低频变异与28天脓毒症生存率降低相关,SAMD9变异为其中之一。
- SAMD9编码组织损伤炎症反应的可能介质。
- 作者认为需要更大样本研究以更好地评估脓毒症生存的遗传效应并验证这些发现。
适用人群与场景
- 第一阶段:GEN-SEP网络中687例欧洲脓毒症患者。
- 第二阶段:MESSI研究中2063例ICU脓毒症患者(1362例欧洲裔美国人,701例非洲裔美国人)。
研究设计与关键结果
- 研究类型:两阶段全基因组关联研究(GWAS),第一阶段在687例欧洲脓毒症患者中对750万个插补变异进行Cox回归分析,调整性别、年龄和遗传变异主要主成分;第二阶段在2063例ICU脓毒症患者(1362例欧洲裔美国人,701例非洲裔美国人)中针对优先变异进行分析,并对两阶段结果进行荟萃分析,显著性阈值p<5.0×10^-8。
- 主要结果:识别出三个独立低频变异与28天脓毒症生存率降低相关,包括SAMD9错义变异(HR 1.64 [95%CI 1.37-6.78],p=4.92×10^-8)。
- SAMD9编码组织损伤炎症反应的可能介质。
- 对识别出的基因和变异进行了全血转录组、功能注释和敏感性分析。
证据类型、等级与局限
- 证据类型:全基因组关联研究(GWAS)。
- 局限:作者指出需要更大样本研究以更好地评估脓毒症生存的遗传效应并验证这些发现。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a severe systemic inflammatory response to infections that is accompanied by organ dysfunction and has a high mortality rate in adult intensive care units. Most genetic studies have identified gene variants associated with development and outcomes of sepsis focusing on biological candidates. We conducted the first genome-wide association study (GWAS) of 28-day survival in adult patients with sepsis.
METHODS: This study was conducted in two stages. The first stage was performed on 687 European sepsis patients from the GEN-SEP network and 7.5 million imputed variants. Association testing was conducted with Cox regression models, adjusting by sex, age, and the main principal components of genetic variation. A second stage focusing on the prioritized genetic variants was performed on 2,063 ICU sepsis patients (1362 European Americans and 701 African-Americans) from the MESSI study. A meta-analysis of results from the two stages was conducted and significance was established at p < 5.0 × 10-8. Whole-blood transcriptomic, functional annotations, and sensitivity analyses were evaluated on the identified genes and variants.
FINDINGS: We identified three independent low-frequency variants associated with reduced 28-day sepsis survival, including a missense variant in SAMD9 (hazard ratio [95% confidence interval] = 1.64 [1.37-6.78], p = 4.92 × 10-8). SAMD9 encodes a possible mediator of the inflammatory response to tissue injury.
INTERPRETATION: We performed the first GWAS of 28-day sepsis survival and identified novel variants associated with reduced survival. Larger sample size studies are needed to better assess the genetic effects in sepsis survival and to validate the findings.
参考来源
- Hernandez-Beeftink T, Guillen-Guio B, Lorenzo-Salazar JM, et al. A genome-wide association study of survival in patients with sepsis. Crit Care. 2022. PMID: 36335405. doi:10.1186/s13054-022-04208-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。